These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group. Forsman H; Winther M; Gabl M; Skovbakke SL; Boulay F; Rabiet MJ; Dahlgren C Biochim Biophys Acta; 2015 Jan; 1853(1):192-200. PubMed ID: 25447672 [TBL] [Abstract][Full Text] [Related]
44. Formyl peptide receptor activation inhibits the expansion of effector T cells and synovial fibroblasts and attenuates joint injury in models of rheumatoid arthritis. Odobasic D; Jia Y; Kao W; Fan H; Wei X; Gu R; Ngo D; Kitching AR; Holdsworth SR; Morand EF; Yang YH Int Immunopharmacol; 2018 Aug; 61():140-149. PubMed ID: 29879657 [TBL] [Abstract][Full Text] [Related]
45. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. Cui YH; Le Y; Gong W; Proost P; Van Damme J; Murphy WJ; Wang JM J Immunol; 2002 Jan; 168(1):434-42. PubMed ID: 11751990 [TBL] [Abstract][Full Text] [Related]
46. Intracellular formyl peptide receptor regulates naïve CD4 T cell migration. Lee HY; Jeong YS; Lee M; Kweon HS; Huh YH; Park JS; Hwang JE; Kim K; Bae YS Biochem Biophys Res Commun; 2018 Feb; 497(1):226-232. PubMed ID: 29427663 [TBL] [Abstract][Full Text] [Related]
47. Antagonism of human formyl peptide receptor 1 (FPR1) by chromones and related isoflavones. Schepetkin IA; Kirpotina LN; Khlebnikov AI; Cheng N; Ye RD; Quinn MT Biochem Pharmacol; 2014 Dec; 92(4):627-41. PubMed ID: 25450672 [TBL] [Abstract][Full Text] [Related]
48. Airway activation of formyl peptide receptors inhibits Th1 and Th17 cell responses via inhibition of mediator release from immune and inflammatory cells and maturation of dendritic cells. Tae YM; Park HT; Moon HG; Kim YS; Jeon SG; Roh TY; Bae YS; Gho YS; Ryu SH; Kwon HS; Kim YK J Immunol; 2012 Feb; 188(4):1799-808. PubMed ID: 22262660 [TBL] [Abstract][Full Text] [Related]
50. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex. Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403 [TBL] [Abstract][Full Text] [Related]
51. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. Quehenberger O; Prossnitz ER; Cavanagh SL; Cochrane CG; Ye RD J Biol Chem; 1993 Aug; 268(24):18167-75. PubMed ID: 8349692 [TBL] [Abstract][Full Text] [Related]
52. The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer. Tian C; Chen K; Gong W; Yoshimura T; Huang J; Wang JM Technol Cancer Res Treat; 2020; 19():1533033820973280. PubMed ID: 33251986 [TBL] [Abstract][Full Text] [Related]
53. A Critical Role of Formyl Peptide Receptors in Host Defense against Zhang M; Gao JL; Chen K; Yoshimura T; Liang W; Gong W; Li X; Huang J; McDermott DH; Murphy PM; Wang X; Wang JM J Immunol; 2020 May; 204(9):2464-2473. PubMed ID: 32221037 [TBL] [Abstract][Full Text] [Related]
54. Biological role of the N-formyl peptide receptors. Panaro MA; Acquafredda A; Sisto M; Lisi S; Maffione AB; Mitolo V Immunopharmacol Immunotoxicol; 2006; 28(1):103-27. PubMed ID: 16684671 [TBL] [Abstract][Full Text] [Related]
55. Formyl peptide receptors in bone research. Lantieri MA; R Perdomo Trejo J; Le Q; Dighe A; Cui Q; Yang X Connect Tissue Res; 2023 May; 64(3):229-237. PubMed ID: 36440821 [TBL] [Abstract][Full Text] [Related]
57. D-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3. Nawaz MI; Rezzola S; Tobia C; Coltrini D; Belleri M; Mitola S; Corsini M; Sandomenico A; Caporale A; Ruvo M; Presta M Angiogenesis; 2020 Aug; 23(3):357-369. PubMed ID: 32152757 [TBL] [Abstract][Full Text] [Related]
58. Novel ureidopropanamide based N-formyl peptide receptor 2 (FPR2) agonists with potential application for central nervous system disorders characterized by neuroinflammation. Stama ML; Ślusarczyk J; Lacivita E; Kirpotina LN; Schepetkin IA; Chamera K; Riganti C; Perrone R; Quinn MT; Basta-Kaim A; Leopoldo M Eur J Med Chem; 2017 Dec; 141():703-720. PubMed ID: 29102463 [TBL] [Abstract][Full Text] [Related]
59. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop. Forsman H; Bylund J; Oprea TI; Karlsson A; Boulay F; Rabiet MJ; Dahlgren C Biochim Biophys Acta; 2013 Aug; 1833(8):1914-23. PubMed ID: 23562731 [TBL] [Abstract][Full Text] [Related]
60. Radiosynthesis and in vivo Evaluation of Carbon-11 (2S)-3-(1H-Indol-3-yl)-2-{[(4-methoxyphenyl)carbamoyl]amino}-N-{[1-(5-methoxypyridin-2-yl)cyclohexyl]methyl}propanamide: An Attempt to Visualize Brain Formyl Peptide Receptors in Mouse Models of Neuroinflammation. Lacivita E; Stama ML; Maeda J; Fujinaga M; Hatori A; Zhang MR; Colabufo NA; Perrone R; Higuchi M; Suhara T; Leopoldo M Chem Biodivers; 2016 Jul; 13(7):875-83. PubMed ID: 27251949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]